# Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

> **NCT02158702** · PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Myeloma
- Relapse After Use of Lenalidomide and Bortezomib

## Interventions

- **DRUG:** Pomalidomide and Dexamethasone

## Key facts

- **NCT ID:** NCT02158702
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2018-02
- **Final completion:** 2018-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158702, "Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02158702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*